Recent Updates
Recently added Catalysts
NAGE Positive Sentiment Score: 70/100

Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Key Takeaway: Niagen Bioscience, Inc. will report its second quarter 2026 financial results on August 4, 2026. A conference call is scheduled for 4:30 p.m. ET to discuss these results. The announcement reflects the company's commitment to transparency and communication with stakeholders.
Price reaction · baseline $3.37 (2026-07-20 close) · hit pre-market · clean, no other NAGE news in the window
day 0 close · peak
+3.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Niagen Bioscience is focused on healthy aging.
  • The company is preparing to share its financial results.
  • The scheduled conference call indicates transparency and engagement with investors.

Full Press Release Details

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Tuesday, August 4, 2026, at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2026. The financial results will be reported in a press release after the close of regular stock market trading hours on Tuesday, August 4, 2026.

Frequently Asked Questions

When will Niagen Bioscience report its Q2 2026 results?

Niagen Bioscience will report its Q2 2026 financial results on August 4, 2026.

What time is the conference call for Q2 results?

The conference call will take place at 4:30 p.m. ET on August 4, 2026.

What is the focus of Niagen Bioscience?

Niagen Bioscience focuses on the science of healthy aging.

How will the financial results be shared?

The financial results will be reported in a press release after market hours.

Last updated: Jul 21, 2026